This article examines the interaction of internal law, its framing of industry practices, and the result when international law requires changes. The widely varying role of the pharmaceutical industry in each of the two countries examined – Brazil and India - results from the way in which domestic law and industry response shaped the competitive foundations of their firms. This study also examines the role of international competition and its affects on internal efforts to satisfy both social and economic goals. The contrast between these countries provides research direction for intellectual property law and business strategy research
This article investigates the implications of the Agreement on Trade-Related Aspects of Intellectual...
Presented at the GLOBELICS 6th International Conference 2008 22-24 September, Mexico City, Mexico
In June 2005, Brazil threatened to infringe the patent of an anti-AIDS medication, Kaletra, patented...
This article analyzes the domestic drivers of regulatory state formation in India and Brazil and its...
In both the economic and political realm, India and Brazil exhibit similar interests and policies. Y...
In both the economic and political realm, India and Brazil exhibit similar interests and policies. Y...
As their economic clout increases, emerging powers are becoming policy-shapers in their own right. T...
As their economic clout increases, emerging powers are becoming policy-shapers in their own right. T...
In this thought-provoking analysis, the author takes three examples of emerging markets (Brazil, Ind...
In June 2005, Brazil threatened to infringe the patent of an anti-AIDS medication, Kaletra, patented...
This article compares national approaches toward secondary pharmaceutical patents. Because secondary...
This article compares national approaches toward secondary pharmaceutical patents. Because secondary...
Since the mid-twentieth century, the national objective of India and Brazil has been to develop indu...
Since the mid-twentieth century, the national objective of India and Brazil has been to develop indu...
Since the mid-twentieth century, the national objective of India and Brazil has been to develop indu...
This article investigates the implications of the Agreement on Trade-Related Aspects of Intellectual...
Presented at the GLOBELICS 6th International Conference 2008 22-24 September, Mexico City, Mexico
In June 2005, Brazil threatened to infringe the patent of an anti-AIDS medication, Kaletra, patented...
This article analyzes the domestic drivers of regulatory state formation in India and Brazil and its...
In both the economic and political realm, India and Brazil exhibit similar interests and policies. Y...
In both the economic and political realm, India and Brazil exhibit similar interests and policies. Y...
As their economic clout increases, emerging powers are becoming policy-shapers in their own right. T...
As their economic clout increases, emerging powers are becoming policy-shapers in their own right. T...
In this thought-provoking analysis, the author takes three examples of emerging markets (Brazil, Ind...
In June 2005, Brazil threatened to infringe the patent of an anti-AIDS medication, Kaletra, patented...
This article compares national approaches toward secondary pharmaceutical patents. Because secondary...
This article compares national approaches toward secondary pharmaceutical patents. Because secondary...
Since the mid-twentieth century, the national objective of India and Brazil has been to develop indu...
Since the mid-twentieth century, the national objective of India and Brazil has been to develop indu...
Since the mid-twentieth century, the national objective of India and Brazil has been to develop indu...
This article investigates the implications of the Agreement on Trade-Related Aspects of Intellectual...
Presented at the GLOBELICS 6th International Conference 2008 22-24 September, Mexico City, Mexico
In June 2005, Brazil threatened to infringe the patent of an anti-AIDS medication, Kaletra, patented...